Filtered By:
Drug: Actos
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 156 results found since Jan 2013.
VIDEO: Post-stroke pioglitazone modestly protective against secondary vascular events
LOS ANGELES – Nondiabetic, insulin-resistant patients who started pioglitazone within 6 months of an ischemic stroke or transient ischemic attack had almost a 3% absolute risk reduction in secondary...
Source: Internal Medicine News - February 19, 2016 Category: Internal Medicine Source Type: research
Feb 19 Cardiology NewsFeb 19 Cardiology News
Carotid stenting vs surgery, leadless pacing, the CMS decision on Watchman, pioglitazone after stroke, and subretinal bleeding with antithrombins are discussed by Dr John Mandrola this week. theheart.org on Medscape
Source: Medscape Cardiology Headlines - February 19, 2016 Category: Cardiology Tags: Cardiology News Source Type: news
Tackling insulin resistance may reduce recurrence after stroke
Giving pioglitazone to stroke survivors with insulin resistance but no overt diabetes reduces their risk of having a recurrent vascular event, shows the randomised Insulin Resistance Intervention after Stroke trial.
Source: MedWire News - February 19, 2016 Category: Consumer Health News Tags: Stroke Source Type: news
Diabetes drug may prevent recurring strokes
Pioglitazone, a drug used for type 2 diabetes, may prevent recurrent stroke and heart attacks in people with insulin resistance but without diabetes. The results of the Insulin Resistance Intervention after Stroke (IRIS) trial, presented at the International Stroke Conference 2016 in Los Angeles and published in the New England Journal of Medicine, suggest a potential new method to prevent stroke and heart attack in high-risk patients who have already had one stroke or transient ischemic attack.
Source: World Pharma News - February 18, 2016 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Pioglitazone for Secondary Prevention in Vascular Disease? (FREE)
By Joe Elia
Edited by Jaye Elizabeth Hefner, MD
Pioglitazone, which lowers insulin resistance, may help in the secondary prevention of vascular events, suggests a study presented at the International Stroke Conference and published in the New England …
Source: Physician's First Watch current issue - February 18, 2016 Category: Primary Care Source Type: news
Diabetes Drug May Help Prevent Second Stroke
Actos reduced risk by 24 percent in people with insulin resistance, research showed
Source: WebMD Health - February 17, 2016 Category: Consumer Health News Source Type: news
Diabetes Drug May Help Prevent Second Stroke: Study
Actos reduced risk by 24 percent in people with insulin resistance, research showed
Source: WebMD Health - February 17, 2016 Category: Consumer Health News Source Type: news
Diabetes drug may prevent heart attack, recurring stroke
Stephen FellerNEW HAVEN, Conn., Feb. 17 (UPI) -- The diabetes drug Actos was shown to lower the risk of recurring stroke and heart attack in a large clinical trial of insulin-resistant stroke patients.
Source: Health News - UPI.com - February 17, 2016 Category: Consumer Health News Source Type: news
Diabetes Drug May Help Prevent Second Stroke
Actos reduced risk by 24 percent in people with insulin resistance, research showed
Source: HealthDay
Related MedlinePlus Pages: Diabetes Medicines, Stroke
Source: MedlinePlus Health News - February 17, 2016 Category: Consumer Health News Source Type: news
Diabetes Drug May Help Prevent Second Stroke: Study
Actos reduced risk by 24 percent in people with insulin resistance, research showed
Source: U.S. News - Health - February 17, 2016 Category: Consumer Health News Source Type: news
IRIS: Diabetes Drug Reduces Recurrent Stroke, MIIRIS: Diabetes Drug Reduces Recurrent Stroke, MI
A randomized trial shows that in patients with insulin resistance but no diabetes and a history of recent stroke or TIA, pioglitazone reduced recurrent stroke and myocardial infarction vs placebo. Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - February 17, 2016 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
New England Journal of Medicine, Ahead of Print.
Source: New England Journal of Medicine - February 17, 2016 Category: Internal Medicine Tags: article Source Type: research
Diabetes Drug May Help Prevent Second Stroke: Study
WEDNESDAY, Feb. 17, 2016 -- The diabetes drug Actos (pioglitazone) appears to protect people who've already had a stroke from suffering a second stroke, a new study finds.
Along with standard treatment after a stroke -- including blood thinners, and...
Source: Drugs.com - Daily MedNews - February 17, 2016 Category: Journals (General) Source Type: news
Diabetes drug may prevent recurring strokes
Pioglitazone, a drug used for type 2 diabetes, may prevent recurrent stroke and heart attacks in people with insulin resistance but without diabetes. The results of the Insulin Resistance Intervention after Stroke (IRIS) trial, presented at the International Stroke Conference 2016 in Los Angeles and published in the New England Journal of Medicine, suggest a potential new method to prevent stroke and heart attack in high-risk patients who have already had one stroke or transient ischemic attack.
Source: NINDS Press Releases and News: National Institute of Neurological Disorders and Stroke - February 17, 2016 Category: Neurology Source Type: news
